Chilton Investment CO Inc. Aerie Pharmaceuticals Inc Transaction History

Chilton Investment CO Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$10.46 - $14.46 $380,545 - $526,069	-36,381 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$12.0 - $16.13 $84,036 - $112,958	-7,003 Reduced 16.14%	36,381 $537,000
Q1 2020 May 06, 2020	SELL	$11.84 - $25.52 $278,157 - $599,541	-23,493 Reduced 35.13%	43,384 $586,000
Q4 2019 Feb 12, 2020	BUY	$17.72 - $25.1 $318,871 - $451,674	17,995 Added 36.81%	66,877 $1.62 Million
Q3 2019 Nov 15, 2019	BUY	$18.41 - $28.0 $899,917 - $1.37 Million	48,882 New	48,882 $940,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

Stay updated on Chilton Investment CO Inc. with notifications on news.